SCHEMBL97990

SCHEMBL97990

COc1ccc(CC2SC(=O)NC2=O)c2ccc(=O)n(C)c12

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.57
PTPN1 P18031 2/20 0.47
PPARG P37231 5/20 0.39
MAPT P10636 2/20 0.39
MAOA P21397 2/20 0.39
CISD1 Q9NZ45 2/20 0.39
MPC2 O95563 1/20 0.39
CYP2C8 P10632 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP19A1 P11511 3/20 0.38
NQO2 P16083 3/20 0.38
KCNH2 Q12809 1/20 0.37
MAOB P27338 1/20 0.37
ALDH1A1 P00352 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HRH3 Q9Y5N1 1/20 0.36
FFAR1 O14842 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL96163 0.89 CA2 (0.46) CA2PTPN1PPARGMAPTMAOA
SCHEMBL97252 0.87 CA2 (0.45) CA2PTPN1PPARGMAPTMAOA
SCHEMBL8228771 0.79 CA2 (0.63) CA2PTPN1PPARGMAPTMAOA
SCHEMBL98412 0.77 CYP19A1 (0.43) CA2PTPN1MAPTCYP19A1NQO2
SCHEMBL13846773 0.76 CA2 (0.66) CA2PTPN1PPARGMAPTMAOA
SCHEMBL96438 0.76 PPARG (0.54) CA2PPARGCYP19A1NQO2ALDH1A1
SCHEMBL13846776 0.73 CA2 (0.69) CA2PTPN1PPARGMAPTMAOA
SCHEMBL13846787 0.73 CA2 (0.58) CA2PTPN1PPARGMAPTMAOA
SCHEMBL8188658 0.73 CA2 (0.81) CA2PTPN1PPARGMAPTMAOA
SCHEMBL11158115 0.73 CA2 (1.00) CA2PTPN1PPARGMAPTMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
EP-1797082-A1 CARBOSTYRIL COMPOUND Otsuka Pharmaceutical Company, Limited (JP) 2007-06-20 EP disclosed
WO-2006035954-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 CA2 254/4885PTPN1 1691/4885PPARG 1682/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 CA2 254/4885PTPN1 1691/4885PPARG 1682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.